Skip to main content
NIH funding notice RFA-NS-23-032

Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)

Closed on November 28, 2023.

Posted
September 26, 2023
Close date
November 28, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,030,416 in first-year total cost, median $1,515,208.

Most frequent study sections

  1. Special Emphasis Panel[ZHD1 DSR-L (55)]2

Most frequent institutions

  1. RESEARCH INST NATIONWIDE CHILDREN'S HOSP1
  2. UNIVERSITY OF FLORIDA1
Competing awards under RFA-NS-23-032 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024MDSRC for Next Directions in Muscular Dystrophy Research1P50HD117373-01A1FLANIGAN, KEVIN MRESEARCH INST NATIONWIDE CHILDREN'S HOSP, OH$1,557,819ZHD1
2024Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center1P50NS132955-01A1SWANSON, MAURICE SCOTTUNIVERSITY OF FLORIDA, FL$1,472,597ZHD1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.